Showing results 3 to 4 of 4
Issue Date | Title | Journal Title |
---|---|---|
2019 | Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer | Annals of Oncology |
2015 | Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma | ONCOTARGET |